Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rosetta Genomics Ltd ROSGQ

Healthcare Biotechnology Diagnostics & Research
Rosetta Genomics Ltd. is an Israel-based company engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA), and protein biomarkers, and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence... see more

Recent & Breaking News (GREY:ROSGQ)

Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology

PR Newswire April 1, 2013

Rosetta Genomics Receives 25th U.S. Patent Allowance

PR Newswire March 18, 2013

Rosetta Genomics to Present at the 25th Annual Roth Conference

PR Newswire March 12, 2013

Rosetta Genomics Receives Two Key U.S. Patent Allowances

PR Newswire February 14, 2013

Study Validating Ability of microRNAs to Predict Progression of Bladder Cancer Published in British Journal of Urology International

PR Newswire February 7, 2013

Rosetta Genomics to be Featured on The Balancing Act® Airing on Lifetime Television Network

PR Newswire January 30, 2013

Top Stocks on the Move: Rosetta Genomics Ltd., Canadian Solar Inc., Interactive Intelligence Group Inc., and Paragon Shipping Inc.

PR Newswire January 10, 2013

Free Research Reports on HOLX, NUVA, ROSG and TSL Issued by the Bedford Report

Marketwired January 10, 2013

Rosetta Genomics Reports Study Comparing microRNA Profiles of Cancer of Unknown Primary and Metastases of Known Primary Tumors Published in Clinical Experimental Metastasis

PR Newswire January 9, 2013

Rosetta Genomics to Present at Sidoti & Company 2013 Micro-Cap Conference

PR Newswire January 4, 2013

The Real Story Behind ACRX, ROSG and PPHM

Marketwired January 2, 2013